Newman,E M

Institution: Department of Hematology/HCT, City of Hope, Duarte, CA, USA

Research Interests: Patients, Leukemia, Schedule, Treatment, Tyrosine, Chemotherapy, mRNA, Reductase, Ribonucleotide Reductase, Tumors, Acute Myelogenous Leukemia, Behavior, Farnesyltransferase, Future, Inhibition, Maximum Tolerated Dose, Minor, Myelogenous Leukemia, Report, Rest